08 December 2000
Molecular and Cellular Events Associated with Ischemia/Reperfusion Injury
J Pratschke, M J WilhelmAnn Transplant 2000; 5(4): 29-35 :: ID: 497550
Abstract
Despite progressive improvement in the early outcome of solid organ transplants, their long-term rate of success remains limited, primarily by chronic rejection and patient death. Although the pathogenesis of chronic rejection is not completely understood, two major types of risk factors have been identified. The most important are immunological, related to genetic differences between donor and recipient and orchestrating a cascade of interrelated events which include the interaction between the major histocompatibility complex (MHC) antigens and T lymphocytes, the influence of co-stimulatory molecules, the activation of different leukocyte populations and the differential regulatory roles of cellassociated chemokines and other inflammatory molecules.
Keywords: adhesion molecules, oxygen-free radicals, polymorphonuclear luekocytes, Organ Transplantation
In Press
Original article
Learning Curve and Outcomes of Pure Laparoscopic Donor Major Hepatectomy Performed by Fellowship-Trained Su...Ann Transplant In Press; DOI: 10.12659/AOT.953061
Original article
Role of Psychological Resilience on Emotional Health in Kidney and Liver Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952824
Original article
Analysis of Factors Influencing the Psychological State of Patients After Autologous Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.953645
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Most Viewed Current Articles
24 Aug 2021 : Review article 21,725
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 17,946
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,696
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,590
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






